Eton Pharmaceuticals, Inc. (ETON)
61.40
+0.04
(+0.07%)
USD |
NASDAQ |
Nov 20, 13:55
Eton Pharmaceuticals Price : 61.40 for Nov. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | 63.28 | 63.38 | 61.01 | 61.36 | 389135.0 |
| Nov 18, 2026 | 63.75 | 64.63 | 61.43 | 61.99 | 488739.0 |
| Nov 17, 2026 | 62.58 | 64.57 | 62.00 | 63.65 | 578908.0 |
| Nov 16, 2026 | 64.29 | 66.73 | 63.50 | 63.88 | 613620.0 |
| Nov 13, 2026 | 61.87 | 65.18 | 61.01 | 63.93 | 601303.0 |
| Nov 12, 2026 | 68.38 | 69.05 | 61.36 | 61.45 | 1.017M |
| Nov 11, 2026 | 66.94 | 70.64 | 64.74 | 68.40 | 1.134M |
| Nov 10, 2026 | 63.63 | 68.38 | 63.63 | 67.54 | 1.176M |
| Nov 09, 2026 | 58.10 | 64.44 | 57.02 | 64.35 | 1.139M |
| Nov 06, 2026 | 58.59 | 58.59 | 51.82 | 56.46 | 1.271M |
| Nov 05, 2026 | 51.15 | 51.97 | 47.03 | 47.15 | 706180.0 |
| Nov 04, 2026 | 51.76 | 52.30 | 49.35 | 50.72 | 375316.0 |
| Nov 03, 2026 | 50.81 | 52.68 | 50.50 | 50.95 | 340603.0 |
| Nov 02, 2026 | 52.92 | 53.75 | 49.49 | 50.81 | 557155.0 |
| Oct 30, 2026 | 53.33 | 53.62 | 51.89 | 52.18 | 336108.0 |
| Oct 29, 2026 | 52.10 | 53.98 | 51.98 | 53.67 | 369438.0 |
| Oct 28, 2026 | 50.67 | 51.97 | 50.51 | 51.80 | 339663.0 |
| Oct 27, 2026 | 50.10 | 51.42 | 49.34 | 51.16 | 340282.0 |
| Oct 26, 2026 | 50.00 | 51.33 | 49.54 | 50.17 | 405284.0 |
| Oct 23, 2026 | 49.89 | 50.71 | 48.75 | 50.00 | 314772.0 |
| Oct 22, 2026 | 49.36 | 50.48 | 48.74 | 50.02 | 483690.0 |
| Oct 21, 2026 | 50.93 | 50.93 | 48.66 | 49.30 | 318993.0 |
| Oct 20, 2026 | 49.36 | 51.12 | 48.88 | 50.19 | 320551.0 |
| Oct 19, 2026 | 50.29 | 50.73 | 48.36 | 49.22 | 375897.0 |
| Oct 16, 2026 | 51.35 | 51.86 | 49.07 | 50.31 | 469034.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Aquestive Therapeutics, Inc. | 3.53 |
| Pfizer Inc. | 27.62 |
| Amneal Pharmaceuticals, Inc. | 21.29 |
| ANI Pharmaceuticals, Inc. | 69.07 |
| Corcept Therapeutics, Inc. | 64.24 |
Price Related Metrics
| PE Ratio | 40.67 |
| PS Ratio | 14.02 |
| Price to Book Value | 20.36 |
| Price to Free Cash Flow | 98.92 |
| Earnings Yield | 2.46% |
| Market Cap | 1.770B |
| Operating PE Ratio | 48.60 |
| Normalized PE Ratio | 40.67 |